Little Green Pharma Signs second exclusive supply deal with Cannamedical
- Little Green Pharma (LGP) Denmark enters a a second agreement with Cannamedical Pharma to exclusively supply its medicinal cannabis cultivar SMS
- LGP may deliver non-irradiated SMS product as an alternative to irradiated SMS product with the goal of delivering the first shipment in the first quarter of 2023
- Further, the agreement will allow the supply of SMS to Cannamedical for sale in Germany, subject to minimum quantities being ordered every six months to maintain exclusivity
- The minimum value of the agreement is about €3 million ($4.5 million) over two years
- Shares in LittleGreen Pharma have ended the day up 2.78 per cent to close at 18.5 cents
